Clinical Trials Browser

Unknown × Hodgkin Disease × Magnetic Resonance Spectroscopy × Clear all

NCT03226249 2023-06-02

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Phase 2 Unknown

30 enrolled 10 charts

Hodgkin Disease